Effectiveness and safety of Lanadelumab according to disease activity: pooled analysis of EMPOWER/ENABLE . Revista Alergia México, [S. l.], v. 72, n. 3, p. 221–222, 2025. DOI: 10.29262/ram.v72i3.1505. Disponível em: https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/1505. Acesso em: 23 sep. 2026.